Fig1

Percent of patients with MACE within 3 years stratified by A: HK vs No-HK; B: HK frequency; and C: HK severity. Figure 1A: The number of patients with 3 years of follow-up was 1,128,582 (no-HK = 983,409, HK = 145,173). Fig. 1B: The number of patients with 3 years of follow-up was 145,173 (transient HK = 73,036, intermittent HK = 67,486, persistent HK = 4,651). Figure 1C: The number of patients with 3 years of follow-up was 145,173 (mild HK = 117,902, moderate HK = 22,879, severe HK = 4,392). HK hyperkalaemia; MACE major adverse cardiovascular event